ATE242219T1 - Histamin h 3 rezeptorliganden - Google Patents

Histamin h 3 rezeptorliganden

Info

Publication number: ATE242219T1
Authority: AT; Austria
Prior art keywords: alkyl; group; groups; pct; independently
Prior art date: 1996-02-09

Application number

AT97902509T

Other languages

English (en)

Inventor

Sarkis Barret Kalindjian

Nigel Paul Shankley

Matthew John Tozer

Iain Mair Mcdonald

Michael John Pether

Elaine Anne Harper

Gillian Fairfull Watt

Tracey Cooke

Caroline Minli Rachel Low

Original Assignee

Black James Foundation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-02-09

Filing date

1997-02-10

Publication date

2003-06-15

1996-02-09 Priority claimed from GBGB9602649.7A external-priority patent/GB9602649D0/en

1997-02-10 Application filed by Black James Foundation filed Critical Black James Foundation

2003-06-15 Application granted granted Critical

2003-06-15 Publication of ATE242219T1 publication Critical patent/ATE242219T1/de

Links

102000004384 Histamine H3 receptors Human genes 0.000 title abstract 2
108090000981 Histamine H3 receptors Proteins 0.000 title abstract 2
239000003446 ligand Substances 0.000 title abstract 2
125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 3
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 2
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
125000004432 carbon atom Chemical group C* 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
-1 imidazoyl Chemical group 0.000 abstract 1
229910052757 nitrogen Inorganic materials 0.000 abstract 1
229910052760 oxygen Inorganic materials 0.000 abstract 1
239000001301 oxygen Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Plural Heterocyclic Compounds (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT97902509T 1996-02-09 1997-02-10 Histamin h 3 rezeptorliganden ATE242219T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9602649.7A GB9602649D0 (en)	1996-02-09	1996-02-09	Histamine h3 receptor ligands
GBGB9624215.1A GB9624215D0 (en)	1996-02-09	1996-11-21	Histamine H3 receptor ligands
PCT/GB1997/000358 WO1997029092A1 (en)	1996-02-09	1997-02-10	Histamine h3 receptor ligands

Publications (1)

Publication Number	Publication Date
ATE242219T1 true ATE242219T1 (de)	2003-06-15

Family

ID=26308645

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97902509T ATE242219T1 (de)	1996-02-09	1997-02-10	Histamin h 3 rezeptorliganden

Country Status (14)

Country	Link
US (1)	US6080871A (de)
EP (1)	EP0882023B1 (de)
JP (1)	JP2000505428A (de)
CN (1)	CN1215392A (de)
AT (1)	ATE242219T1 (de)
AU (1)	AU709611B2 (de)
CA (1)	CA2244745A1 (de)
DE (1)	DE69722592D1 (de)
HU (1)	HUP9901190A3 (de)
NO (1)	NO312762B1 (de)
NZ (1)	NZ331272A (de)
PL (1)	PL328369A1 (de)
RU (1)	RU2182904C2 (de)
WO (1)	WO1997029092A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU715604B2 (en) *	1996-04-03	2000-02-03	Merck & Co., Inc.	Inhibitors of farnesyl-protein transferase
GB9715814D0 (en) *	1997-07-25	1997-10-01	Black James Foundation	Histamine H3 receptor ligands
US6407132B1 (en) *	1997-07-25	2002-06-18	James Black Foundation Limited	Substituted imidazole derivatives and their use as histamine H3 receptor ligands
GB2344588B (en) *	1997-07-25	2001-11-14	Black James Foundation	1H-4(5)-substituted imidazole derivatives their preparation and their use as histamine H 3 receptor ligands
GB9803536D0 (en)	1998-02-19	1998-04-15	Black James Foundation	Histamine H,receptor ligands
US6503935B1 (en) *	1998-08-07	2003-01-07	Abbott Laboratories	Imidazoles and related compounds as α1A agonists
CN1960969B (zh)	2004-04-01	2012-03-28	伊莱利利公司	组胺h3受体药物、其制备方法及治疗用途
EP1595881A1 (de)	2004-05-12	2005-11-16	Pfizer Limited	Tetrahydronaphthyridin-Derivate, verwendbar als Histamin H3 Rezeptor-Liganden
FR2870846B1 (fr) *	2004-05-25	2006-08-04	Sanofi Synthelabo	Derives de tetrahydroisoquinolylsulfonamides, leur preparation et leur utilisation en therapeutique
US7705025B2 (en)	2004-08-23	2010-04-27	Eli Lilly And Company	Histamine H3 receptor agents, preparation and therapeutic uses
PE20060500A1 (es) *	2004-08-24	2006-07-13	Janssen Pharmaceutica Nv	Derivados de heteroaril sulfamida benzo-fusionada como anticonvulsivantes
US7846950B2 (en)	2004-10-18	2010-12-07	Eli Lilly And Company	Histamine H3 receptor inhibitors, preparation and therapeutic uses
EP1707203A1 (de)	2005-04-01	2006-10-04	Bioprojet	Verwendung von Alkylaminen, die kein Imidazole enthalten, als Histamin H3 Rezeptor Liganden, zur Behandlung von Morbus Parkinson, obstruktiver Schlafapnoe, vaskularer Demenz, Demenz mit Lewy Korpen
WO2006107661A1 (en)	2005-04-01	2006-10-12	Eli Lilly And Company	Histamine h3 receptor agents, preparation and therapeutic uses
EP1717233A1 (de) *	2005-04-29	2006-11-02	Bioprojet	Liganden für den Histamin H3-Rezeptor und ihre therapeutische Anwendung
EP1717235A3 (de)	2005-04-29	2007-02-28	Bioprojet	Phenoxypropylpiperidine und -pyrrolidine und ihre Verwendung als Liganden für den Histamin H3-Rezeptor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2372066A (en) *	1940-12-23	1945-03-20	Parke Davis & Co	Biological product and process of obtaining same
US3497591A (en) *	1968-11-19	1970-02-24	Colgate Palmolive Co	Dental preparations containing imidazole derivative
EP0082648A3 (de) *	1981-12-21	1984-09-26	Imperial Chemical Industries Plc	Cephalosporinderivate
DE3219113A1 (de) *	1982-05-21	1983-11-24	Bayer Ag, 5090 Leverkusen	Verwendung von n-substituierten 2,3-diaminocarbonsaeuren in arzneimitteln und ihre herstellung
AU5410786A (en) *	1985-03-04	1986-09-11	Fujisawa Pharmaceutical Co., Ltd.	Amino acid derivatives and processes for preparation thereof
US5447728A (en) *	1992-06-15	1995-09-05	Emisphere Technologies, Inc.	Desferrioxamine oral delivery system
FR2686084B1 (fr) *	1992-01-10	1995-12-22	Bioprojet Soc Civ	Nouveaux derives de l'imidazole, leur preparation et leurs applications therapeutiques.
AU7823894A (en) *	1993-08-27	1995-03-21	Vrije Universiteit	New imidazole derivatives having agonistic or antagonistic activity on the histamine h3 receptor

1997
- 1997-02-10 AU AU16136/97A patent/AU709611B2/en not_active Ceased
- 1997-02-10 NZ NZ331272A patent/NZ331272A/xx unknown
- 1997-02-10 EP EP97902509A patent/EP0882023B1/de not_active Expired - Lifetime
- 1997-02-10 PL PL97328369A patent/PL328369A1/xx unknown
- 1997-02-10 AT AT97902509T patent/ATE242219T1/de not_active IP Right Cessation
- 1997-02-10 US US09/117,808 patent/US6080871A/en not_active Expired - Fee Related
- 1997-02-10 CN CN97193599A patent/CN1215392A/zh active Pending
- 1997-02-10 HU HU9901190A patent/HUP9901190A3/hu unknown
- 1997-02-10 JP JP9528300A patent/JP2000505428A/ja active Pending
- 1997-02-10 CA CA002244745A patent/CA2244745A1/en not_active Abandoned
- 1997-02-10 DE DE69722592T patent/DE69722592D1/de not_active Expired - Lifetime
- 1997-02-10 RU RU98116955/04A patent/RU2182904C2/ru active
- 1997-02-10 WO PCT/GB1997/000358 patent/WO1997029092A1/en not_active Ceased
1998
- 1998-08-05 NO NO19983596A patent/NO312762B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
PL328369A1 (en)	1999-01-18
JP2000505428A (ja)	2000-05-09
RU2182904C2 (ru)	2002-05-27
US6080871A (en)	2000-06-27
WO1997029092A1 (en)	1997-08-14
NZ331272A (en)	2000-01-28
CN1215392A (zh)	1999-04-28
HUP9901190A3 (en)	2002-05-28
EP0882023B1 (de)	2003-06-04
CA2244745A1 (en)	1997-08-14
NO312762B1 (no)	2002-07-01
NO983596D0 (no)	1998-08-05
DE69722592D1 (de)	2003-07-10
HUP9901190A2 (hu)	1999-09-28
EP0882023A1 (de)	1998-12-09
AU709611B2 (en)	1999-09-02
NO983596L (no)	1998-09-16
AU1613697A (en)	1997-08-28

Legal Events

Date	Code	Title	Description
2003-12-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE69722592D1 (de)	2003-07-10	Histamin h 3 rezeptorliganden
DK1309544T3 (da)	2009-03-02	Forbindelser, der virker som melanocortinreceptorligander
DK0665844T3 (da)	2000-10-16	Substituerede benzylaminoquinuclidinforbindelser som antagonister af substans P
ATE154576T1 (de)	1997-07-15	Verflüssiger für wassersuspendierte partikeln und pasten aus hydraulischen bindern
GB0018272D0 (en)	2000-09-13	Chemical compounds IV
MX9801410A (es)	1998-05-31	Nuevas n-aminoalquilfluorencarboxamidas; una nueva clase de ligandos especificos del subtipo del receptor de la dopamina.
NO943055L (no)	1994-10-11	Bicyklo[2.2.2.Åoktanderivater som cholestocystokininhemmere
GB8518741D0 (en)	1985-08-29	Process
GR861927B (en)	1986-09-05	Process for preparing heterocyclic compounds
ES8106715A1 (es)	1981-09-01	Un procedimiento para la obtencion de agentes bloqueantes del receptor h2 de la histamina
TR200001239T2 (tr)	2001-07-23	Tiyazolidinediyon türevlerini hazırlama prosesi.
IL100164A0 (en)	1992-08-18	Indan derivatives
HUP9900679A2 (hu)	1999-09-28	Simaizom sejtburjánzást gátló benzimidazolszármazékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
ES486071A1 (es)	1980-09-01	Un procedimiento para la preparacion de derivados de amina
ES2070623T3 (es)	1995-06-01	Oxisulfonilureas inhibidoras de acat.
ES8608498A1 (es)	1986-07-16	Procedimiento para la obtencion de fenoxialquilaminopropano-les substituidos
GB2341862A (en)	2000-03-29	Histamine H3 receptor ligands
ES514634A0 (es)	1983-05-01	"un procedimiento para la preparacion de 2-(1,4-benzodioxan-2-il-metil)-imidazolina".
DK0782574T3 (da)	2002-05-06	Bicycliske carboxiamider som 5-HT1A-receptorligander
KR960007560A (ko)	1996-03-22	신규한 아민 유도체, 그의 제조방법 및 항부정맥제로서의 용도
ES471895A1 (es)	1979-10-01	Procedimiento para preparar derivados de benzamidina
DK0619817T3 (da)	1999-09-27	Hidtil ukendte farmaceutisk aktive flaviliumforbindelser
DK1068199T3 (da)	2003-03-03	N-Aryloxyethyl-indolyl-alkylaminer til behandling af depression
MY104048A (en)	1993-10-30	New allylaminoethylazoles.